Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth Sells 4,000 Shares

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 4,000 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $4,415,201.28. The trade was a 3.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66.

Trupanion Price Performance

Shares of TRUP stock opened at $38.61 on Tuesday. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The firm has a market capitalization of $1.64 billion, a price-to-earnings ratio of -167.87, a PEG ratio of 6.02 and a beta of 1.70. The stock’s 50-day simple moving average is $41.54 and its 200-day simple moving average is $46.71.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. As a group, equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on TRUP shares. Piper Sandler reduced their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Trupanion has an average rating of “Moderate Buy” and a consensus target price of $46.60.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently made changes to their positions in TRUP. FMR LLC lifted its position in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the period. Balyasny Asset Management L.P. raised its stake in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after buying an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Trupanion by 170.7% in the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock valued at $16,248,000 after buying an additional 212,545 shares during the period. Freestone Grove Partners LP purchased a new stake in shares of Trupanion in the fourth quarter worth about $7,776,000. Finally, Baillie Gifford & Co. grew its holdings in Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after acquiring an additional 147,341 shares during the period.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.